Balance Sheet

Assets

-6%

+30%

10Y

Currency: USD

	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024	Dec-2025
Assets
Cash & Cash Equivalents	123	182	208	115	175	225	244	183	179	69	110	156	160	118	118	164	195	238	228	241	234	277	195	214
Cash Equivalents	123	182	208	115	175	225	244	183	179	69	110	156	160	118	118	164	195	238	228	241	234	277	195	214
Short-Term Investments	0	13	0	2	8	15	0	55	10	5	7	11	0	0	4	29	1	1	1	1	1	0	0	0
Total Receivables	94	112	202	171	203	214	210	190	193	185	203	221	258	270	364	430	472	514	618	650	752	780	721	709
Accounts Receivables	94	112	202	171	203	214	210	190	193	185	203	221	258	270	364	430	472	514	618	643	752	780	721	709
Other Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	8	0	0	0	0
Inventory	44	52	62	65	72	88	97	103	100	93	89	89	89	94	96	115	128	161	186	199	256	380	279	299
Other Current Assets	17	12	39	66	43	66	67	65	71	74	77	75	72	78	76	89	101	108	168	182	196	171	209	225
Total Current Assets	278	371	510	419	501	608	618	596	553	426	485	553	579	559	657	827	898	1 021	1 201	1 274	1 439	1 609	1 403	1 447
PP&E Net	188	204	357	388	535	749	837	864	753	738	717	676	677	678	756	782	933	1 184	1 303	1 584	1 857	2 034	2 017	2 017
PP&E Gross	188	204	357	388	535	749	837	864	753	738	717	676	677	678	756	782	933	1 184	1 303	1 584	1 857	2 034	2 017	2 017
Accumulated Depreciation	183	218	244	267	315	372	374	443	504	557	596	646	655	645	706	801	874	978	1 086	1 103	1 161	1 335	1 454	1 538
Intangible Assets	34	30	256	175	160	149	136	154	121	93	85	85	179	281	394	370	611	689	788	1 061	955	864	723	340
Goodwill	97	105	1 423	1 098	1 119	1 121	458	508	198	198	209	231	321	439	788	805	1 247	1 541	1 809	2 712	2 850	3 095	2 847	2 764
Long-Term Investments	0	7	4	18	104	49	19	16	11	17	9	18	0	33	45	17	89	123	222	201	312	244	218	207
Other Long-Term Assets	105	82	76	440	138	131	73	67	97	87	82	71	115	79	72	130	79	134	169	192	190	350	320	361
Other Assets	97	105	1 423	1 098	1 119	1 121	458	508	198	198	209	231	321	439	788	805	1 247	1 541	1 809	2 712	2 850	3 095	2 847	2 764
Total Assets	701 N/A	800 +14%	2 627 +229%	2 538 -3%	2 558 +1%	2 806 +10%	2 141 -24%	2 204 +3%	1 733 -21%	1 558 -10%	1 586 +2%	1 633 +3%	1 871 +15%	2 069 +11%	2 712 +31%	2 930 +8%	3 856 +32%	4 693 +22%	5 491 +17%	7 024 +28%	7 603 +8%	8 195 +8%	7 528 -8%	7 135 -5%
Liabilities
Accounts Payable	13	19	29	29	28	37	41	31	31	34	31	32	34	37	69	78	66	112	123	198	206	169	140	149
Accrued Liabilities	60	61	116	80	84	115	116	95	109	98	95	117	139	162	178	191	244	318	381	508	463	496	466	597
Short-Term Debt	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Current Portion of Long-Term Debt	3	0	81	36	25	25	36	35	31	15	139	21	32	17	27	31	31	39	50	3	4	6	3	3
Other Current Liabilities	40	34	124	167	122	126	109	89	90	70	77	77	90	96	156	164	216	242	286	324	419	385	385	372
Total Current Liabilities	116	114	349	311	259	303	301	250	260	217	342	247	295	312	430	464	558	710	840	1 033	1 092	1 055	994	1 120
Long-Term Debt	190	186	606	260	547	485	480	457	670	703	527	642	741	846	1 208	1 114	1 637	1 850	1 930	2 664	2 708	2 647	2 240	2 136
Deferred Income Tax	0	4	93	40	56	71	48	43	30	16	13	15	23	48	56	90	144	167	217	240	216	191	107	95
Minority Interest	19	10	10	10	9	4	0	1	1	2	2	24	32	33	17	19	21	32	29	57	47	62	47	47
Other Liabilities	20	21	96	91	90	83	71	80	85	95	101	64	108	97	165	199	179	299	361	496	565	642	679	572
Total Liabilities	344 N/A	335 -3%	1 154 +245%	711 -38%	962 +35%	945 -2%	900 -5%	829 -8%	1 046 +26%	1 033 -1%	986 -5%	992 +1%	1 198 +21%	1 335 +11%	1 875 +40%	1 885 +1%	2 539 +35%	3 058 +20%	3 376 +10%	4 489 +33%	4 626 +3%	4 598 -1%	4 067 -12%	3 971 -2%
Equity
Common Stock	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	1	0
Retained Earnings	233	153	63	79	23	178	353	239	575	466	368	266	139	11	165	289	42	280	625	981	1 433	1 887	1 812	1 389
Additional Paid In Capital	602	610	1 519	1 778	1 818	1 907	2 016	2 039	1 997	2 057	2 097	2 206	2 308	2 398	2 477	2 560	1 448	1 532	1 628	1 718	1 805	1 906	1 966	1 947
Unrealized Security Profit/Loss	0	0	0	0	0	0	2	2	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Treasury Stock	0	0	0	18	268	310	426	471	769	1 071	1 136	1 306	1 423	1 541	1 553	1 660	0	0	0	0	0	0	0	0
Other Equity	12	7	16	12	21	86	6	47	34	6	7	5	74	136	254	145	173	178	139	165	262	196	317	172
Total Equity	357 N/A	465 +30%	1 473 +217%	1 827 +24%	1 595 -13%	1 861 +17%	1 241 -33%	1 375 +11%	687 -50%	526 -24%	601 +14%	641 +7%	672 +5%	733 +9%	837 +14%	1 045 +25%	1 317 +26%	1 635 +24%	2 115 +29%	2 535 +20%	2 976 +17%	3 597 +21%	3 462 -4%	3 165 -9%
Total Liabilities & Equity	701 N/A	800 +14%	2 627 +229%	2 538 -3%	2 558 +1%	2 806 +10%	2 141 -24%	2 204 +3%	1 733 -21%	1 558 -10%	1 586 +2%	1 633 +3%	1 871 +15%	2 069 +11%	2 712 +31%	2 930 +8%	3 856 +32%	4 693 +22%	5 491 +17%	7 024 +28%	7 603 +8%	8 195 +8%	7 528 -8%	7 135 -5%
Shares Outstanding
Common Shares Outstanding	45	46	66	72	67	68	67	66	56	49	48	48	47	47	47	47	48	49	50	50	51	51	51	49

Income Statement Balance Sheet Cash Flow Statement

Charles River Laboratories International Inc
NYSE:CRL

Balance Sheet

Balance Sheet Decomposition
Charles River Laboratories International Inc

Balance Sheet
Charles River Laboratories International Inc

See Also

Company

Help

Tools

Stocks

Charles River Laboratories International Inc NYSE:CRL

Balance Sheet

Balance Sheet Decomposition Charles River Laboratories International Inc

Balance Sheet Charles River Laboratories International Inc

See Also

Company

Help

Tools

Stocks

Charles River Laboratories International Inc
NYSE:CRL

Balance Sheet Decomposition
Charles River Laboratories International Inc

Balance Sheet
Charles River Laboratories International Inc